Dr Jim Ross, who comes from Kilmarnock, has been awarded a grant from the Association for International Cancer Research (AICR) to investigate the role of Proteolysis Inducing Factor - or PIF - in prostate cancer spread following the discovery by US scientists of a link with advanced breast cancer.
Dr Ross of the Tissue Injury and Repair Group at the University of Edinburgh’s Medical School explains: "Over half of all patients with advanced prostate cancer will develop cancer cachexia which is the name of the syndrome of weight loss, loss of appetite and anaemia associated with advanced malignancy.”
"The weight loss of cancer cachexia is associated with a lower survival rate and poorer response to chemotherapy and radiotherapy. And, with even a five per cent weight loss it leads to a worse prognosis than for a cancer patient of normal weight."
Recently, scientists have discovered that starving cancer cells of oxygen will cause many tumour cells to perish. However, paradoxically, the hardiest of prostate cancer cells will survive these harsh conditions and flourish. It is now thought that low oxygen levels allow the selection of prostate cancer cells which become more aggressive and eventually lead to spread of the cancer to other sites, rendering the disease incurable.
Adds Dr Ross: " PIF has also been identified as permitting survival of breast cancer cells when they are grown in the low oxygen conditions present in a tumour and may allow these cancer cells to survive, divide and spread. Breast cancers not able to produce PIF are less likely to be able to survive these conditions and are less aggressive. Recently, PIF has also been found in some prostate cancers and our study will investigate its role in allowing the survival of prostate cancer cells in an oxygen-reduced environment."
According to Dr Mark Matfield, AICR's scientific adviser if PIF is found to support survival of prostate cancer cells then it would be a good target for future treatment of a cancer which currently claims the lives of more than 10,000 UK men every year.
"Dr Ross and his colleagues, Professor Kenneth Fearon and Drs Grant Stewart and Fouad Habib, will study improved methods of detecting PIF in cells and bodily secretions such as urine. The hope is to be able to produce a new detection method and to target these patients with novel drugs to treat weight-loss associated with cancer."
Derek Napier, AICR's Chief Executive says the three-year grant, worth more than £100,000, has been given in line with the charity's policy of funding the most novel approaches to research worldwide. “This is an exciting project set to tackle one of the most challenging problems facing cancer researchers. However, these are early days and it could be some time before it is known whether it will lead to effective drugs to help treat cancer patients,” he cautions.
Susan Osborne | alfa
Study tracks inner workings of the brain with new biosensor
16.08.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn
Foods of the future
15.08.2018 | Georg-August-Universität Göttingen
New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference
Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...
Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...
Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.
When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...
Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.
Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....
Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.
Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...
17.08.2018 | Event News
08.08.2018 | Event News
27.07.2018 | Event News
17.08.2018 | Physics and Astronomy
17.08.2018 | Information Technology
17.08.2018 | Life Sciences